GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders

GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

DMGT leads round for Ozempic-style alcohol reduction startup

Nul, a British health tech startup building an “alcohol reduction platform”, has secured a $1m (£730,000) seed round led by the venture arm of Daily Mail and General Trust (DMGT). The startup is developing a digital health platform that combines clinical care and prescription medication with digital pathways and behavioural support to reduce alcohol consumption. The idea is similar to GLP 1, an appetite suppressing hormone used in popular weight…